effect
colostr
matern
antibodi
ab
acquir
via
colostrum
passiv
protect
develop
system
mucos
immun
respons
rotaviru
evalu
neonat
calv
colostrumdepriv
cd
calv
calv
receiv
one
dose
pool
control
colostrum
cc
immun
colostrum
ic
contain
titer
bovin
rotaviru
brv
respect
oral
inocul
ffu
ind
p
brv
day
age
calv
monitor
daili
diarrhea
viru
shed
antibrvab
fece
elisa
antirotaviru
ab
titer
serum
evalu
weekli
isotypespecif
elisa
viru
neutral
vn
day
postinocul
dpi
anim
euthan
number
antibrv
antibodi
secret
cell
asc
intestin
system
lymphoid
tissu
evalu
elispot
colostrum
intak
ic
calv
significantli
higher
serum
titer
gmt
cc
cd
calv
brv
inocul
anim
becam
infect
mean
durat
viru
shed
day
howev
ic
calv
significantli
fewer
day
diarrhea
day
compar
cd
cc
calv
day
respect
group
receiv
colostrum
delay
onset
diarrhea
viru
shed
associ
fece
serum
fece
cd
cc
calv
peak
antibrv
igm
titer
dpi
iga
respons
significantli
lower
cc
calv
antibodi
titer
detect
serum
fece
associ
circul
asc
isotyp
blood
ic
calv
igm
respons
fece
dpi
antibrv
asc
respons
observ
analyz
tissu
three
group
except
bone
marrow
intestin
main
site
asc
respons
brv
highest
iga
asc
number
invers
relationship
passiv
titer
magnitud
asc
respons
fewer
asc
cc
calv
significantli
lower
asc
number
isotyp
ic
calv
thu
passiv
antibrv
neg
affect
activ
immun
respons
dosedepend
manner
ileal
peyer
patch
igm
asc
predomin
calv
receiv
colostrum
asc
predomin
cd
calv
presenc
ic
calv
fece
absenc
asc
respons
consist
transfer
serum
back
gut
contribut
protect
intestin
mucosa
group
bovin
rotaviru
brv
major
caus
neonat
diarrhea
calv
worldwid
saif
et
al
calv
expos
brv
third
week
life
remain
suscept
least
week
age
kohara
tsunemitsu
saif
et
al
bovin
rotaviru
produc
villou
atrophi
malabsorpt
diarrhea
infect
apic
villou
epitheli
cell
intestin
given
earli
suscept
calv
brv
infect
local
passiv
ab
iga
gut
lumen
acquir
colostrum
milk
play
import
role
protect
brv
infect
diseas
saif
et
al
saif
et
al
addit
high
titer
passiv
circul
ab
shown
complementari
role
protect
brv
diarrhea
due
transfer
serum
intestin
neonat
calv
besser
et
al
b
saif
et
al
saif
et
al
direct
correl
viru
neutral
vn
ab
titer
serum
neonat
beef
calv
protect
brv
diseas
field
condit
describ
kohara
tsunemitsu
serum
antibodi
essenti
dairi
calv
separ
dam
colostrum
intak
fed
subsequ
milk
replac
lack
antibodi
due
signific
econom
loss
caus
brv
infect
cattl
inactiv
vaccin
administ
pregnant
cow
use
extens
sinc
middl
immun
dam
greatli
increas
ab
colostrum
use
effect
vaccin
intramammari
rout
milk
ab
also
increas
kim
et
al
saif
fernandez
saif
et
al
henc
protect
diarrhea
neonat
calv
born
vaccin
cow
might
relat
passiv
matern
ab
serum
acquir
intak
colostrum
dairi
calv
serum
colostr
intestin
milk
antibodi
suckl
beef
calv
kinet
primari
antibodi
respons
differ
isotyp
brv
well
vn
ab
respons
describ
colostrumf
colostrumdepriv
gnotobiot
convent
calv
fernandez
et
al
saif
et
al
saif
et
al
saif
smith
howev
magnitud
distribut
antibodi
secret
cell
asc
involv
develop
system
mucos
antibodymedi
immun
presenc
passiv
matern
ab
evalu
cattl
studi
conduct
mice
cd
gnotobiot
pig
indic
rotaviru
infect
antirv
asc
mainli
locat
intestin
lamina
propria
mesenter
lymph
node
asc
present
spleen
blood
blutt
et
al
hodgin
et
al
yuan
et
al
addit
studi
passiv
protect
gnotobiot
convent
pig
show
high
titer
passiv
circul
colostr
acquir
matern
antibodi
confer
high
protect
rate
rotaviru
infect
diseas
ward
et
al
howev
high
titer
passiv
matern
ab
also
significantli
reduc
asc
respons
rv
infect
system
gutassoci
lymphoid
tissu
pig
contrast
littl
known
asc
respons
rv
infect
system
mucosalassoci
lymphoid
tissu
rumin
modul
presenc
matern
ab
asc
respons
blood
gnotobiot
lamb
rv
infect
measur
antirv
iga
igg
asc
present
dpi
van
pinxteren
et
al
aim
present
studi
investig
develop
activ
abmedi
immun
respons
brv
calv
experiment
challeng
brv
presenc
absenc
colostr
ab
experiment
design
give
calv
singl
oral
dose
pool
control
colostrum
unvaccin
cow
immun
colostrum
rotaviru
vaccin
cow
shortli
birth
follow
milk
without
ab
close
mimic
rotaviru
vaccin
manag
practic
current
use
dairi
cattl
better
understand
mucos
immun
respons
brv
infect
calv
improv
immun
strategi
control
gastrointestin
diseas
cattl
experiment
design
colostrum
feed
calf
inocul
newborn
holstein
male
cd
calv
procur
dairi
farm
remov
mother
birth
prior
suckl
transport
isol
facil
within
first
h
life
anim
locat
individu
isol
room
control
condit
briefli
anim
umbil
cord
disinfect
iodin
receiv
intramuscular
dose
vitamin
vitamin
u
vitamin
u
vitamin
e
mg
bago
laboratori
sa
bs
argentina
mg
selenium
selfo
agroinsumo
bs
argentina
entri
prevent
bacteri
infect
calv
maintain
antibiot
therapi
consist
g
per
day
gentamicin
equi
system
srl
martinez
bs
argentina
administ
intraven
g
per
day
cefalosporin
cefalomicinabago
laboratori
sa
bs
argentina
administ
intramuscularli
first
day
five
eight
calv
randomli
assign
follow
colostrum
feed
group
colostrumdepriv
cd
control
colostrum
cc
immun
colostrum
ic
colostrumf
calv
receiv
l
control
immun
colostrum
pool
within
first
h
life
initi
colostrum
intak
calv
fed
l
milk
without
antibodi
commerci
steril
bovin
milk
human
consumpt
mastellon
hno
bs
argentina
twice
day
calv
oral
inocul
third
fourth
feed
approxim
h
colostrum
intak
ml
inoculum
contain
ffu
virul
ind
brv
previous
verifi
caus
diarrhea
viru
shed
inocul
cd
calv
calv
observ
onset
diarrhea
associ
clinic
sign
anorexia
hyperthermia
rectal
temperatur
regist
daili
brv
inocul
fecal
consist
score
follow
normal
pasti
semiliquid
liquid
score
equal
greater
consid
diarrhea
fecal
sampl
collect
brv
inocul
daili
assess
viru
shed
serum
sampl
collect
initi
colostrum
feed
within
h
birth
inocul
weekli
day
postinocul
dpi
antibodi
serum
brv
detect
elisa
vn
coproantibodi
evalu
elisa
peripher
blood
lymphocyt
obtain
dpi
weekli
follow
activ
immun
respons
enzymelik
immunospot
elispot
assay
dpi
anim
euthan
number
antirv
asc
quantifi
elispot
mucosalassoci
lymphoid
tissu
duodenum
jejunum
ileal
lamina
propria
lp
jejunum
ileal
peyer
patch
pp
jejunum
cecal
mesenter
lymph
node
mln
system
lymphoid
tissu
spleen
bone
marrow
larg
lic
small
sic
intestin
content
calv
collect
dpi
ab
detect
virul
ind
brv
p
use
calf
inocul
consist
intestin
content
cd
calf
oral
inocul
fecal
suspens
contain
virul
brv
gnotobiot
calf
kindli
suppli
dr
l
saif
ohio
state
univers
usa
briefli
cd
calf
oral
inocul
fecal
suspens
contain
ffu
ind
brv
anim
euthan
h
onset
diarrhea
entir
intestin
content
collect
pool
aliquot
store
pool
infecti
titer
ffuml
doublestrand
rna
electropherotyp
inocul
strain
virus
detect
intestin
content
electron
microscopi
bacteri
pathogen
identifi
standard
bacteriolog
isol
techniqu
cellcultur
adapt
ind
brv
propag
monkey
kidney
cell
use
elispot
elisa
viru
neutral
vn
assay
prepar
immun
colostrum
pool
nine
pregnant
holstein
cow
vaccin
intramuscularli
three
dose
ml
attenu
ind
brv
vaccin
day
calv
vaccin
formul
use
tissu
cultur
supernat
ind
brv
ffuml
emulsifi
equal
volum
incomplet
freund
adjuv
entir
first
milk
cow
collect
whey
sampl
obtain
milk
describ
previous
vn
elisa
ab
titer
determin
immun
colostrum
pool
prepar
colostrum
six
cow
highest
ab
titer
antibrv
rang
first
milk
five
nonvaccin
dairi
cow
herd
collect
prepar
control
colostrum
pool
milk
select
antibrv
titer
resembl
averag
titer
detect
survey
previous
conduct
nonvaccin
dairi
cow
data
shown
case
select
colostrum
pool
mix
thoroughli
aliquot
store
use
whey
sampl
prepar
pool
determin
vn
elisa
ab
titer
rotaviru
shed
detect
fecal
sampl
use
ag
captur
elisa
previous
describ
cornaglia
et
al
polyacrylamid
gel
electrophoresi
page
perform
fecal
sampl
correspond
peak
viru
shed
confirm
viru
shed
calf
challeng
strain
brv
ind
laemmli
viru
infecti
titer
assess
cell
cultur
immunofluoresc
ccif
assay
briefli
calf
fecal
sampl
dilut
mem
clarifi
centrifug
min
g
tenfold
serial
dilut
sampl
assay
duplic
plate
contain
cell
monolay
incub
cell
fix
aceton
fluoresc
foci
visual
use
fitcconjug
hyperimmun
bovin
antiserum
ind
brv
fluoresc
fociform
cell
count
use
fluoresc
microscop
titer
express
number
fluoresc
form
unit
per
ml
ffuml
igm
iga
igg
ab
ind
brv
detect
colostrum
pool
calf
sera
fece
lic
sic
detect
indirect
elisa
use
reagent
protocol
previous
describ
fernandez
et
al
igm
iga
measur
use
captur
elisa
adapt
previous
describ
assay
use
antibovin
igm
mab
kindli
suppli
dr
lj
saif
ohio
state
univers
usa
affin
purifi
sheep
antibovin
iga
polyclon
antibodi
bethyl
laboratori
inc
montgomeri
tex
captur
naslund
et
al
van
zaan
et
al
crossreact
latter
commerci
ab
check
immunodiffus
nonspecif
reaction
observ
assay
standard
accord
ab
titer
known
brv
posit
serum
colostrum
sampl
fernandez
et
al
neg
sampl
dilut
assign
titer
calcul
geometr
mean
titer
gmt
viru
neutral
ab
titer
ind
brv
colostrum
pool
determin
fluoresc
focu
neutral
ffn
test
describ
vn
titer
express
reciproc
highest
sampl
dilut
result
reduct
number
fluoresc
foci
approxim
cm
tissu
sampl
duodenum
jejunum
ileum
collect
isol
cell
lamina
propria
discret
peyer
patch
identifi
differ
point
along
mucos
surfac
jejunum
surround
intestin
tissu
care
separ
pp
collect
segment
intestin
correspond
portion
distal
ileum
continu
peyer
patch
cm
cranial
ileocaec
junction
also
obtain
evalu
antibrv
asc
respons
mln
drain
small
larg
intestin
mln
correspond
jejunum
ilealcec
region
collect
process
separ
peyer
patch
mln
local
sampl
supervis
histopathologist
intestin
tissu
initi
digest
dithiotreithol
gibco
brl
grand
island
ny
usa
collagenas
type
ii
sigma
chemic
co
st
loui
mo
usa
mnc
suspens
obtain
centrifug
percol
amersham
pharmacia
biotech
upsala
sweden
follow
densiti
gradient
percol
previous
describ
pig
tissu
yuan
et
al
mononuclear
cell
blood
spleen
bone
marrow
extract
evalu
asc
respons
system
lymphoid
tissu
bone
marrow
collect
proxim
onethird
femur
suspend
ca
mg
free
hank
balanc
salt
solut
gibco
brl
grand
island
ny
usa
tissu
pass
stainless
steel
screen
cell
collector
cellector
ec
apparatu
corp
petersburg
fl
usa
mononuclear
cell
bone
marrow
blood
isol
lymphoprep
nycom
pharma
diagnost
oslo
norway
densiti
gradient
centrifug
follow
recommend
manufactur
purifi
mnc
tissu
resuspend
final
concentr
mncml
gibco
brl
grand
island
ny
usa
supplement
fc
mm
hepe
mm
glutamin
mm
sodium
pyruv
mm
nonessenti
aminoacid
iuml
penicillin
mgml
streptomycin
mgml
gentamycin
erpmi
cell
viabil
mnc
suspens
assess
trypan
blue
exclus
case
elispot
assay
quantif
antibrv
igm
iga
asc
use
evalu
effector
bcell
respons
inocul
calv
assay
adapt
conduct
pig
yuan
et
al
briefli
ind
brv
infect
cell
plate
fix
aceton
air
dri
store
use
plate
use
show
infect
ccif
qualiti
plate
also
confirm
elispot
assay
use
rvspecif
hybridoma
cell
clone
secret
brv
specif
mab
kindli
suppli
dr
lj
saif
ohio
state
univers
usa
singlecel
suspens
mnc
tissu
ad
duplic
well
cellswel
centrifug
g
min
plate
incub
h
co
plate
wash
remov
adher
cell
spot
develop
use
two
differ
protocol
base
either
mab
polyclon
ab
assay
use
commerci
polyclon
ab
develop
less
expens
less
labor
intens
altern
mab
antibodi
assay
sampl
evalu
use
elispot
system
monoclon
antibodi
protocol
plate
incub
h
mab
ascit
bovin
igm
provid
dr
l
saif
ohio
state
univers
usa
commerci
monoclon
ab
bovin
iga
clone
tissu
cultur
supernat
serotec
uk
follow
addit
dilut
goat
biotinlabel
affin
purifi
ab
mous
iga
igg
igm
kpl
gaithersburg
md
usa
h
room
temperatur
plate
wash
incub
horseradish
peroxidaseconjug
streptavidin
boehringermannheim
indianapoli
usa
min
room
temperatur
spot
develop
tetramethylbenzidin
peroxidas
substrat
system
kpl
gaithersburg
md
usa
polyclon
antibodi
protocol
order
standard
less
expens
less
time
consum
procedur
elispot
assay
duplic
plate
incub
parallel
set
commerci
peroxidaselabel
sheep
polyclon
ab
bovin
igm
iga
bethyl
laboratori
inc
montgomeri
tex
h
room
temperatur
spot
develop
describ
neg
control
cd
calv
use
techniqu
standard
sampl
seed
rvinfect
mockinfect
cell
monolay
nonspecif
spot
detect
latter
addit
asc
detect
mnc
collect
prior
brv
inocul
experiment
calv
elispot
plate
enumer
singl
oper
experienc
elispot
techniqu
order
provid
consist
interpret
statist
concord
elispot
assay
develop
use
monoclon
polyclon
ab
bovin
ig
determin
use
blandaltman
graphic
method
data
shown
altman
analysi
accept
differ
spot
count
two
assay
spot
igm
spot
iga
spot
percentag
sampl
discord
spot
count
higher
describ
limit
igm
iga
total
sampl
process
analysi
indic
good
concord
assay
final
number
antirv
mnc
tissu
determin
mean
number
blue
spot
obtain
develop
system
least
four
replic
cell
dilut
consid
calcul
fisher
exact
test
use
compar
proport
calv
diarrhea
viru
shed
among
group
kruskal
walli
rank
sum
nonparametr
test
use
compar
day
onset
durat
diarrhea
viru
shed
cumul
diarrhea
score
cumul
titer
viru
shed
day
hyperthermia
among
treatment
group
neutral
isotypespecif
ab
titer
log
transform
prior
statist
analysi
differ
ab
titer
among
group
evalu
gener
analysi
varianc
anova
model
repeat
measur
throughout
time
follow
gener
contrast
postanova
test
dpi
asc
number
compar
among
group
use
kruskal
walli
rank
sum
test
statist
signific
assess
p
comparison
statist
analys
conduct
use
statistix
analyt
softwar
tallahase
usa
titer
vn
ab
ind
brv
bovin
colostrum
pool
summar
tabl
immun
colostrum
pool
vn
titer
higher
control
colostrum
pool
immun
colostrum
pool
iga
titer
fourfold
higher
control
colostrum
pool
pool
neg
brv
immun
pool
low
igm
titer
colostrum
intak
ic
calv
receiv
immun
colostrum
significantli
higher
antibrv
ab
gmt
vn
serum
cc
calv
given
control
colostrum
vn
cd
calv
vn
number
cow
group
entir
first
milk
colostrum
rang
lcow
collect
pool
mix
thoroughli
b
determin
fluoresc
focu
form
unit
reduct
assay
c
neg
sampl
dilut
assign
titer
calcul
ratio
ic
ratio
ic
ratio
ab
titer
immun
control
colostrum
pool
e
applic
fig
coproantibodi
decreas
low
titer
gmt
rang
ic
calv
undetect
cc
calv
dpi
fig
high
titer
passiv
antibodi
confer
partial
protect
brv
diarrhea
fail
prevent
infect
inocul
brv
ic
calv
fulli
protect
diseas
wherea
three
anim
develop
delay
less
sever
diarrhea
shorter
durat
day
compar
cd
cc
calv
mean
day
respect
tabl
anim
three
group
becam
infect
mean
durat
viru
shed
day
significantli
differ
among
group
kruskal
walli
p
amount
viru
shed
significantli
differ
either
mean
peak
titer
ffuml
p
mean
cumul
titer
ffuml
p
howev
colostrumdepriv
calv
shortest
mean
durat
viru
shed
group
homogen
calv
receiv
control
colostrum
high
intragroup
variabl
amount
durat
viru
shed
fig
calv
receiv
colostrum
show
delay
onset
viru
shed
significantli
delay
ic
calv
day
compar
cd
fig
geometr
mean
isotyp
ab
titer
gmt
ind
brv
detect
daili
fece
colostrumdepriv
calv
cd
b
calv
receiv
one
dose
l
control
colostrum
cc
c
immun
colostrum
ic
within
first
h
life
fed
commerci
bovin
milk
without
antibodi
anim
oral
inocul
day
h
colostrum
intak
dpi
euthan
dpi
sic
small
intestin
content
lic
larg
intestin
content
collect
dpi
calv
day
tabl
p
fig
cd
calv
began
shed
viru
within
dpi
delay
onset
viru
shed
observ
cc
calv
dpi
ic
calv
dpi
associ
progress
decreas
titer
ab
detect
fece
fig
anim
show
hyperthermia
onset
infect
longer
durat
cd
calv
compar
calv
receiv
colostrum
cc
ic
significantli
tabl
p
isotypespecif
vn
ab
respons
ind
brv
serum
number
antirv
asc
pbl
detect
weekli
depict
fig
isotypespecif
ab
respons
ind
brv
fece
evalu
daili
lic
sic
determin
dpi
shown
fig
cd
calv
peak
igm
respons
serum
dpi
concomit
strong
iga
respons
peak
dpi
follow
respons
fig
predomin
isotyp
dpi
viru
neutral
ab
respons
also
detect
dpi
cc
ic
calv
maintain
initi
serum
level
passiv
acquir
neutral
ab
cc
calv
develop
igm
respons
dpi
delay
iga
respons
dpi
significantli
lower
cd
calv
igm
iga
respons
detect
sera
ic
calv
ab
respons
detect
anim
day
experiment
period
fig
antibrv
asc
detect
blood
calv
onset
experi
dpi
fig
igm
asc
peak
respons
detect
pbl
anim
dpi
simultan
iga
asc
dpi
lower
number
asc
associ
increas
titer
passiv
antibodi
cc
ic
calv
although
significantli
dpi
highest
number
igm
iga
asc
detect
cd
calv
dpi
cd
cc
calv
ic
calv
low
number
asc
dpi
fig
cd
calv
develop
high
igm
iga
coproantibodi
respons
igm
detect
dpi
peak
dpi
iga
also
detect
earli
dpi
remain
high
level
dpi
respons
detect
dpi
dpi
cc
calv
show
similar
profil
ab
respons
igm
iga
respons
lower
magnitud
shorter
durat
compar
cd
calv
low
titer
detect
intermitt
fece
anim
group
one
three
calv
cc
group
longer
period
brv
shed
day
diarrhea
day
calf
bloodi
fece
day
day
ab
detect
fece
period
also
dpi
unknown
whether
enter
pathogen
besid
brv
contribut
sever
diseas
calf
two
anim
mild
diarrhea
ab
detect
fece
dpi
contrast
ic
calv
high
titer
passiv
rang
fece
time
inocul
titer
decreas
sharpli
rang
dpi
simultan
onset
viru
shed
titer
fece
stay
low
viru
shed
increas
slightli
day
clearanc
infect
remain
present
throughout
entir
experi
dpi
activ
ab
respons
induc
brv
infect
ic
calv
evid
igm
peak
fecal
sampl
dpi
howev
iga
ab
detect
group
calv
except
one
calf
brief
iga
respons
fece
dpi
cd
cc
calv
resolut
brv
infect
associ
presenc
fecal
igm
iga
respons
contrast
ic
calv
cessat
viru
shed
associ
igm
respons
low
level
passiv
fig
dpi
antibodi
predomin
sic
three
group
calv
titer
higher
lic
fece
dpi
calv
intestin
content
cd
cc
calv
iga
wherea
igm
ab
undetect
three
group
calv
addit
calv
iga
coproantibodi
titer
higher
iga
sic
lic
fig
compar
ab
titer
detect
differ
portion
intestin
anim
sic
alway
higher
lic
fece
three
group
calv
suggest
degrad
intestin
antibodi
transit
intestin
compar
ab
titer
correspond
intestin
content
among
group
ic
calv
highest
geometr
mean
titer
sic
gmt
cd
cc
ic
kruskal
walli
p
contrast
cd
cc
calv
iga
sic
indic
activ
respons
ic
calv
iga
cd
significantli
higher
ic
gmt
cd
cc
ic
kruskal
walli
p
intestin
lymphoid
tissu
dpi
rotavirusspecif
asc
respons
neonat
calv
mainli
local
small
intestin
lamina
propria
peyer
patch
follow
mnl
spleen
bone
marrow
number
igm
iga
antibrv
asc
determin
elispot
depict
fig
rotaviru
asc
respons
detect
lymphoid
tissu
test
except
bone
marrow
data
shown
suggest
cattl
bone
marrow
site
asc
colon
primari
immun
respons
brv
major
asc
detect
intestin
lamina
propria
duodenum
jejunum
ileum
jejun
ileal
peyer
patch
mln
drain
small
larg
intestin
fewer
asc
spleen
pbl
dpi
cd
calv
show
reduc
number
igm
asc
tissu
analyz
suggest
calv
alreadi
convalesc
period
infect
contrast
higher
number
igm
asc
detect
tissu
cc
calv
tissu
compar
mean
asc
number
isotyp
among
treatment
group
bar
indic
signific
differ
compar
cd
calv
bar
indic
signific
differ
cc
ic
calv
kruskal
walli
rank
sum
test
p
antibr
asc
detect
bone
marrow
data
shown
n
number
calv
group
compar
cd
calv
significantli
higher
number
duodenum
spleen
immun
colostrum
calv
show
fewer
igm
asc
cd
calv
analyz
tissu
except
ileal
peyer
patch
high
mean
number
igm
asc
detect
ileal
peyer
patch
three
group
calv
cd
cc
ic
igm
mnc
noteworthi
cd
calv
predomin
isotyp
ileal
peyer
patch
follow
igm
iga
high
mean
igm
count
group
due
one
anim
especi
high
respons
isotyp
igm
asc
iga
asc
mnc
contrast
calv
receiv
passiv
colostr
igm
asc
predomin
averag
ratio
cc
ic
calv
respect
jejun
peyer
patch
igm
also
predomin
isotyp
asc
calv
receiv
colostrum
cd
calv
iga
asc
detect
tissu
cd
calv
dpi
highest
number
detect
intestin
lamina
propria
duodenum
ileum
jejunum
iga
mnc
indic
intestin
lamina
propria
especi
duodenum
dpi
main
site
iga
product
calv
similar
number
intestin
iga
asc
except
ileum
lp
slightli
higher
number
system
lymphoid
tissu
detect
cc
calv
compar
cd
calv
contrast
ic
calv
iga
asc
respons
greatli
suppress
tissu
significantli
reduc
number
duodenum
ileal
peyer
patch
cd
calv
activ
immun
respons
brv
character
high
number
asc
tissu
analyz
dpi
especi
duodenum
ileum
lamina
propria
suggest
also
play
import
role
calf
mucos
immun
respons
absenc
passiv
contrast
fewer
number
asc
detect
tissu
cc
calv
compar
cd
calv
significantli
fewer
number
ileal
lamina
propria
ileal
peyer
patch
spleen
almost
asc
detect
ic
calv
consist
lack
detect
titer
serum
fece
asc
detect
blood
dpi
system
intestin
lymphoid
tissu
cd
ic
calv
dpi
howev
cc
group
two
anim
show
asc
respons
one
cc
calf
asc
spleen
detect
monoclon
polyclon
reagent
calf
show
asc
duodenum
jejunum
detect
polyclon
reagent
present
studi
evalu
develop
activ
serum
fecal
ab
respons
brv
infect
number
antibrv
asc
system
mucosalassoci
lymphoid
tissu
convent
calv
influenc
high
low
matern
ab
colostr
ingest
neonat
first
hour
life
mainli
transfer
intact
across
small
intestin
absorpt
epithelium
calf
circul
compart
equilibrium
circul
amount
transfer
immunoglobulin
report
increas
cranial
caudal
small
intestin
ileum
region
major
absorpt
calv
jochim
et
al
passiv
circul
ab
although
associ
protect
rv
infect
also
known
interfer
develop
activ
immun
respons
neonat
aldridg
et
al
hodgin
et
al
et
al
henc
studi
two
properti
protect
immun
interfer
evalu
studi
ab
titer
control
immun
colostrum
select
resembl
present
colostrum
nonvaccin
vaccin
cow
respect
order
evalu
impact
base
current
use
parenter
inactiv
matern
vaccin
oral
inocul
dpi
approxim
h
colostrum
intak
ic
calv
significantli
higher
ab
titer
serum
fece
cc
calv
passiv
acquir
ab
titer
vn
initi
detect
serum
remain
high
throughout
experi
contrast
fecal
antibrv
detect
colostrum
feed
decreas
sharpli
dpi
day
age
suggest
progress
elimin
nonabsorb
colostr
antibodi
fece
within
subsequ
day
report
previous
calv
receiv
l
colostrum
low
titer
antibrv
ab
within
first
h
life
follow
milk
without
ab
fecal
day
age
van
zaan
et
al
ic
calv
detect
ab
fece
throughout
experi
highest
titer
sic
dpi
fecal
titer
reduc
viru
shed
immedi
increas
thereaft
remain
approxim
constant
observ
togeth
absenc
asc
peripher
blood
analyz
weekli
intestin
system
lymphoid
tissu
test
dpi
group
calv
strongli
suggest
detect
fece
due
transfer
passiv
circul
serum
gut
transport
took
place
least
day
colostrum
intak
intestin
elimin
propos
main
rout
passiv
igg
clearanc
calv
amount
excret
intestin
proport
serum
concentr
besser
et
al
b
transfer
igg
serum
gut
also
report
gnotobiot
pig
inject
intraperiton
matern
ab
convent
pig
fed
colostrum
high
antirv
ab
titer
ward
et
al
howev
transfer
mechan
remain
unknown
speci
recent
detect
fcrn
receptor
capabl
bidirect
ph
depend
igg
transport
gut
epithelium
rodent
human
lamb
suggest
similar
receptor
could
involv
process
calv
antoh
et
al
borvak
et
al
dickinson
et
al
israel
et
al
mayer
et
al
simist
ree
brv
inocul
calv
three
group
becam
infect
onset
durat
viru
shed
diarrhea
cd
calv
similar
report
previou
studi
fernandez
et
al
saif
et
al
howev
group
calv
receiv
colostrum
onset
viru
shed
delay
fecal
titer
decreas
lower
describ
previou
studi
calv
fed
steril
milk
supplement
immun
bovin
colostrum
daili
day
age
fernandez
et
al
saif
et
al
presenc
local
play
major
role
protect
brv
infect
diarrhea
present
studi
although
calv
receiv
one
dose
control
colostrum
within
h
birth
protect
brv
infect
show
slightli
delay
diarrhea
shorter
durat
compar
cd
calv
higher
titer
passiv
colostr
fail
prevent
brv
infect
significantli
reduc
brv
diarrhea
ic
calv
protect
observ
calv
might
due
neutral
brv
combin
residu
colostr
ab
present
intestin
time
inocul
transfer
gut
circul
besser
et
al
kohara
tsunemitsu
howev
import
note
clearanc
viru
shed
ic
calv
observ
develop
activ
igm
respons
gut
elisa
vn
data
show
cd
calv
develop
strong
primari
immun
respons
serum
fece
allow
rapid
clearanc
brv
infect
cc
calv
significantli
lower
igm
iga
ab
respons
serum
delay
respons
fece
compar
cd
calv
wherea
antibodi
respons
ic
calv
even
strongli
suppress
short
durat
viru
shed
cd
calv
associ
strong
local
igm
iga
respons
clearanc
infect
colostrumf
calv
igm
respons
highlight
import
local
activ
immun
resolv
brv
infect
result
obtain
calv
consist
previou
find
gnotobiot
pig
receiv
differ
titer
passiv
circul
ab
present
studi
found
low
passiv
ab
titer
cc
calv
impair
develop
activ
immun
respons
enough
protect
infect
diseas
observ
togeth
high
incid
brv
cattl
clearli
indic
calv
born
nonvaccin
dam
highli
suscept
brv
diarrhea
hand
protect
effect
high
colostr
titer
significantli
reduc
brv
diarrhea
viru
shed
help
explain
current
commerci
vaccin
effect
prevent
brv
infect
although
significantli
reduc
morbid
sever
diarrhea
mortal
field
trial
bellinzoni
et
al
cornaglia
et
al
design
improv
parenter
vaccin
capabl
induc
high
titer
ab
direct
neutral
antigen
brv
colostrum
milk
would
best
option
control
brv
diseas
beef
herd
absenc
detect
titer
ab
brv
serum
follow
inocul
detect
asc
brv
two
calv
suggest
antibodi
isotyp
play
minor
role
immun
respons
neonat
calv
viru
essenti
recoveri
brv
infect
noteworthi
find
studi
strong
iga
respons
detect
serum
cd
cc
calv
data
agre
high
titer
serum
iga
describ
gnotobiot
pig
monogastr
lamb
rumin
rv
infect
et
al
van
pinxteren
et
al
disagre
low
iga
respons
detect
cd
colostrumf
calv
previou
report
fernandez
et
al
saif
et
al
van
zaan
et
al
discrep
could
explain
higher
analyt
sensit
captur
elisa
use
assay
avoid
interisotyp
competit
impair
detect
isotyp
present
lower
titer
case
iga
presenc
high
titer
passiv
high
igm
iga
respons
bovin
coronaviru
detect
serum
colostrum
milk
use
similar
approach
naslund
et
al
three
group
calv
antirv
asc
detect
peripher
blood
dpi
asc
respons
profil
observ
blood
cd
calv
similar
report
gnotobiot
pig
yuan
et
al
differ
profil
describ
gnotobiot
lamb
high
number
antirv
iga
igg
asc
detect
dpi
van
pinxteren
et
al
invers
relationship
observ
number
asc
detect
blood
amount
colostr
matern
antibodi
present
serum
agre
result
report
pig
studi
distribut
rvspecif
asc
differ
lymphoid
tissu
dpi
show
antirv
asc
present
tissu
analyz
except
bone
marrow
report
previous
piglet
yuan
et
al
contrast
studi
conduct
mice
system
viral
infect
show
bone
marrow
one
major
site
asc
local
ochsenbein
et
al
sangster
et
al
differ
highlight
compartment
mucosalassoci
system
immun
system
asc
respons
cd
calv
absenc
matern
ab
character
high
number
asc
tissu
analyz
intestin
lamina
propria
especi
duodenum
main
site
iga
asc
local
iga
asc
count
high
contrast
peyer
patch
mln
spleen
number
asc
clearli
predomin
iga
observ
agreement
recent
studi
conduct
mice
b
cell
activ
gut
lamina
propria
peyer
patch
home
lamina
propria
switch
preferenti
iga
b
cell
activ
gut
lamina
propria
peyer
patch
home
peyer
patch
switch
igg
higher
effici
fagarasan
et
al
differenti
isotyp
switch
might
relat
differenti
microenviron
among
differ
lymphoid
tissu
immunolog
studi
indic
transform
growth
factor
b
tgfb
togeth
mice
human
cattl
tgfb
recent
identifi
factor
igainduc
protein
igip
cattl
factor
relat
iga
switch
product
austin
et
al
brandtzaeg
et
al
griebel
hein
stavnez
dpi
cc
calv
lower
asc
along
higher
igm
asc
number
analyz
tissu
compar
cd
calv
except
duodenum
jejunum
lamina
propria
reduct
asc
especi
notic
mln
spleen
blood
tissu
close
contact
circul
ab
contrast
although
higher
number
igm
asc
detect
lamina
propria
duodenum
jejunum
cc
calv
number
asc
unaffect
low
level
passiv
ab
observ
shift
asc
respons
profil
suggest
low
titer
passiv
ab
may
impair
delay
isotyp
switch
strongli
suppress
asc
respons
observ
ic
calv
clearli
indic
passiv
colostr
suppress
b
cell
respons
dosedepend
manner
discoveri
tcell
independ
pathway
induct
secretori
iga
gastrointestin
mucosa
litinskiy
et
al
macpherson
et
al
open
new
question
intestin
immun
respons
rotavirus
postul
tcell
independ
pathway
involv
product
secretori
iga
antibodi
destin
gut
lumen
predominantli
locat
lamina
propria
contrast
serum
iga
antibodi
consid
product
tdepend
pathway
organ
lymphoid
tissu
respons
serum
fecal
iga
antibodi
brv
document
present
studi
similar
result
report
human
infant
ward
et
al
bishop
et
al
gnotobiot
pig
suggest
multipl
pathway
gener
iga
ab
respons
rotavirus
asc
respons
ileal
peyer
patch
noteworthi
cd
calv
asc
predomin
iga
igm
calv
contrast
calv
receiv
colostrum
increas
number
igm
asc
detect
reduct
cc
calv
complet
absenc
ic
calv
iga
asc
calv
sheep
bcelltcel
composit
jejun
peyer
patch
correspond
secondari
lymphoid
organ
also
evid
studi
b
cell
asc
respons
jejun
pp
group
mirror
correspond
asc
spleen
fig
contrast
ileal
peyer
patch
contain
b
cell
parson
et
al
postul
mainli
function
primari
lymphoid
organ
recent
studi
conduct
neonat
lamb
model
mucos
immun
asc
detect
direct
antigen
inocul
intestin
loop
contain
ileal
peyer
patch
suggest
nonparticip
immun
respons
mutwiri
et
al
contrast
result
present
studi
show
activ
particip
calf
ileal
peyer
patch
antibodi
respons
infect
brv
final
accumul
high
number
igm
asc
ileal
peyer
patch
ic
calv
suggest
passiv
might
inhibit
isotyp
switch
igm
iga
earli
stage
mucos
immun
respons
studi
need
better
defin
function
differ
bovin
peyer
patch
mucos
immun
knowledg
first
descript
magnitud
distribut
asc
respons
brv
infect
modul
passiv
colostr
ab
calv
effector
bcell
respons
antibodymedi
respons
brv
infect
calv
mainli
local
intestin
lamina
propria
peyer
patch
follow
mln
spleen
bone
marrow
involv
effector
ab
respons
brv
intestin
lamina
propria
especi
duodenum
major
site
antibrv
iga
asc
local
demonstr
passiv
colostr
ab
neg
affect
develop
mucos
system
abmedi
immun
respons
brv
dosedepend
manner
presenc
fece
intestin
content
calv
receiv
high
titer
immun
colostrum
absenc
activ
asc
intestin
support
theori
transfer
serum
gut
previous
report
calv
